Jonathan Slonin - Jun 6, 2023 Form 4 Insider Report for Pacira BioSciences, Inc. (PCRX)

Role
Chief Clinical Officer
Signature
/s/ Kristen Williams, Attorney-in-Fact
Stock symbol
PCRX
Transactions as of
Jun 6, 2023
Transactions value $
-$36,919
Form type
4
Date filed
6/7/2023, 09:32 PM
Previous filing
Aug 5, 2022
Next filing
Dec 7, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCRX Common Stock Sale -$18.4K -471 -1.26% $38.99 36.8K Jun 6, 2023 Direct F1, F2
transaction PCRX Common Stock Sale -$18.6K -490 -1.33% $37.87 36.3K Jun 7, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.
F2 Includes 205 shares of common stock acquired under the issuer's employee stock purchase plan in December 2022.